deltatrials

Metastatic colorectal cancer Trials in Padua, Italy

Conditions / Metastatic colorectal cancer / Padua, Italy

Clinical trials for Metastatic colorectal cancer investigate a range of treatment strategies and patient populations.

19 total trials for this combination

Showing top 10 of 19 trials

Trials

NCT ID Title Status Phase
NCT02083653 Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer COMPLETED PHASE2
NCT05330429 Study of Magrolimab Given Together With FOLFIRI/Bevacizumab (BEV) in Participants With Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC) TERMINATED PHASE2
NCT03869892 Phase III Study in First-line Treatment of Patients With Metastatic Colorectal Cancer Who Are Not Candidate for Intensive Therapy. ACTIVE_NOT_RECRUITING PHASE3
NCT02077868 Evaluation of MGN1703 Maintenance Treatment in Patients With mCRC With Tumor Reduction During Induction Treatment UNKNOWN PHASE3
NCT03306394 A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic). COMPLETED PHASE3
NCT04008030 A Study of Nivolumab, Nivolumab Plus Ipilimumab, or Investigator's Choice Chemotherapy for the Treatment of Participants With Deficient Mismatch Repair (dMMR)/Microsatellite Instability High (MSI-H) Metastatic Colorectal Cancer (mCRC) ACTIVE_NOT_RECRUITING PHASE3
NCT01030042 Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic Patients COMPLETED PHASE3
NCT05217446 A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer ACTIVE_NOT_RECRUITING PHASE2
NCT05608044 A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer ACTIVE_NOT_RECRUITING PHASE2
NCT04322539 A Study of Efficacy and Safety of Fruquintinib (HMPL-013) in Participants With Metastatic Colorectal Cancer COMPLETED PHASE3

Related Pages